Threats of Zika virus transmission for Asia and its Hindu-Kush Himalayan region (original) (raw)

Zika virus in Asia

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017

Zika virus (ZIKV) is an emerging mosquito-borne virus that was first isolated from a sentinel rhesus monkey in the Zika Forest in Uganda in 1947. In Asia, the virus was isolated in Malaysia from Aedes aegypti mosquitoes in 1966, and the first human infections were reported in 1977 in Central Java, Indonesia. In this review, all reported cases of ZIKV infection in Asia as of September 1, 2016 are summarized and some of the hypotheses that could currently explain the apparently low incidence of Zika cases in Asia are explored.

New Paradigms for Virus Detection, Surveillance and Control of Zika Virus Vectors in the Settings of Southeast Asia

Frontiers in microbiology, 2016

Zika virus (ZIKV) has now become a global public health concern. The vectors for ZIKV are Aedes aegypti and A. albopictus. Both these mosquitoes are predominant in Southeast Asia and are also responsible for the spread of other arboviral diseases like dengue virus and chikungunya virus. The incidence of dengue has been increasing over the years and this is of concern to public health workers. Simple laboratory tools for the detection of ZIKV is also lacking. In the absence of drugs and vaccine for these arboviral diseases, vector control is the main option for surveillance and control. Aedes larval surveys have been the hallmark of dengue control along with larviciding and fogging when cases are reported. However, we need new paradigms and options for control of these vectors. The current situation in Southeast Asia clearly proves that effective strategies for vector control need to be proactive and not reactive. This will be the way forward to control epidemics of these diseases in...

Nation-wide vector surveillance on Zika and Dengue did not indicate transmission of the “American lineage pandemic ZIKA virus” in India

International Journal of Infectious Diseases, 2021

Objectives: Following the Public Health Emergency of International Concern declared on Zika by the World Health Organization during 2016, the Indian Council of Medical Research carried out nationwide vector surveillance for Zika and Dengue viruses (ZIKV and DENV) in India as a preparedness measure in 2016-19. Methods: High-risk zones distributed to 49 Districts in 14 states/union territories were included in the study. Seven ICMR institutions participated, following a standard operating protocol. Aedes specimens sampled weekly were processed by multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) for ZIKV/DENV and random samples crosschecked with real-time RT-PCR for ZIKV. Results: Altogether, 79 492 Aedes specimens in 6492 pools were processed; 3 (0.05%) and 63 (0.97%) pools, respectively, were found positive for ZIKV and DENV. ZIKV infections were recorded in Aedes aegypti sampled during the 2018 sporadic Zika outbreak in Jaipur, Rajasthan. However, these belonged to the Asian lineage of the virus, already circulating in the country. Both Ae. aegypti and Aedes albopictus distributed to 8 states/union territories were found to be infected with DENV. Both sexes of Ae. albopictus were infected, indicating transovarial transmission. Conclusion: This investigation evinced no active transmission of the American lineage-pandemic Zika virus in India during the pandemic period.

History of ZIKV Infections in India and Management of Disease Outbreaks

Frontiers in Microbiology

Zika virus (ZIKV) is an emerging arbovirus infection endemic in multiple countries spread from Asia, Africa to the Americas and Europe. Previously known to cause rare and fairly benign human infections, ZIKV has become a major international public health emergency after being linked to unexpected neurological complications, that includes fetal brain damage/death and microcephaly in babies born to infected mothers and Guillain-Barre syndrome (GBS) in adults. It appears that a single genetic mutation in the ZIKV genome, likely acquired during explosive ZIKV outbreak in French Polynesia (2013), made virus causing mild disease to target fetus brain. The Aedes mosquitoes are found to be the main carrier of ZIKV, passing the virus to humans. Originally isolated from patients in Africa in 1954 (African lineage), virus disseminated to Southeast Asia (Asian lineage), establishing new endemic foci, including one in India. Numerous cases of ZIKV infection have been reported in several locations in India and neighboring countries like Pakistan and Bangladesh since mid of the last century, suggesting that the virus reached this part of Asia soon after it was first discovered in Uganda in 1947. Although, the exact means by which ZIKV was introduced to India remains unknown, it appears that the ZIKV strain circulating in India possibly belongs to the "Asian lineage," which has not yet been associated with microcephaly and other neurological disorders. However, there still exists a threat that the contemporary ZIKV virulent strain from South America, carrying a mutation can return to Asia, posing a potential crisis to newborns and adult patients. Currently there is no specific vaccine or antiviral medication to combat ZIKV infection, thus, vector control and continuous monitoring of potential ZIKV exposure is essential to prevent the devastating consequences similar to the ones experienced in Brazil. However, the major obstacle faced by Indian healthcare agencies is that most cases of ZIKV infection have been reported in rural areas that lack access to rapid diagnosis of infection. In this review, we attempt to present a comprehensive analysis of what is currently known about the ZIKV infection in India and the neighboring countries.

Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases

Annual review of medicine, 2017

Arthropod-borne viruses (arboviruses) have a long history of emerging to infect humans, but during recent decades, they have been spreading more widely and affecting larger populations. This is due to several factors, including increased air travel and uncontrolled mosquito vector populations. Emergence can involve simple spillover from enzootic (wildlife) cycles, as in the case of West Nile virus accompanying geographic expansion into the Americas; secondary amplification in domesticated animals, as seen with Japanese encephalitis, Venezuelan equine encephalitis, and Rift Valley fever viruses; and urbanization, in which humans become the amplification hosts and peridomestic mosquitoes, mainly Aedes aegypti, mediate human-to-human transmission. Dengue, yellow fever, chikungunya, and Zika viruses have undergone such urban emergence. We focus mainly on the latter two, which are recent arrivals in the Western Hemisphere. We also discuss a few other viruses with the potential to emerge ...

The emergence of Zika virus as a global health security threat: A review and a consensus statement of the INDUSEM Joint Working Group (JWG)

The Zika virus (ZIKV), first discovered in 1947, has emerged as a global public health threat over the last decade, with the accelerated geographic spread of the virus noted during the last 5 years. The World Health Organization (WHO) predicts that millions of cases of ZIKV are likely to occur in the Americas during the next 12 months. These projections, in conjunction with suspected Zika-associated increase in newborn microcephaly cases, prompted WHO to declare public health emergency of international concern. ZIKV-associated illness is characterized by an incubation period of 3-12 days. Most patients remain asymptomatic (i.e., ~80%) after contracting the virus. When symptomatic, clinical presentation is usually mild and consists of a self-limiting febrile illness that lasts approximately 2-7 days. Among common clinical manifestations are fever, arthralgia, conjunctivitis, myalgia, headache, and maculopapular rash. Hospitalization and complication rates are low, with fatalities being extremely rare. Newborn microcephaly, the most devastating and insidious complication associated with the ZIKV, has been described in the offspring of women who became infected while pregnant. Much remains to be elucidated about the timing of ZIKV infection in the context of the temporal progression of pregnancy, the corresponding in utero fetal development stage(s), and the risk of microcephaly. Without further knowledge of the pathophysiology involved, the true risk of ZIKV to the unborn remains difficult to quantify and remediate. Accurate, portable, and inexpensive point-of-care testing is required to better identify cases and manage the current and future outbreaks of ZIKV, including optimization of preventive approaches and the identification of more effective risk reduction strategies. In addition, much more work needs to be done to produce an effective vaccine. Given the rapid geographic spread of ZIKV in recent years, a coordinated local, regional, and global effort is needed to generate sufficient resources and political traction to effectively halt and contain further expansion of the current outbreak.

Measuring Mosquito-borne Viral Suitability in Myanmar and Implications for Local Zika Virus Transmission

PLoS Currents

View Correction. Common mosquito-borne viruses (MBVs) of global health concern include the dengue (DENV), chikungunya (CHIKV), Zika (ZIKV), yellow fever (YFV), Rift Valley fever (RVFV), West-Nile (WNV) and Japanese encephalitis (JEV) viruses. Due to ongoing globalization and climatic trends that favour the establishment of vectors and movement of infectious hosts, these pathogens are becoming increasingly detrimental for human public health. The evolutionary and host-pathogen history of MBVs is vastly diverse, but the population biology of these viruses shares one unifying characteristic: their epidemiological dynamics and epidemic behaviour is inherently linked to the underlying population dynamics of their vector-species. Mosquito-population dynamics are known to be dictated by a wide range of factors, such as climate, altitude, population density of humans or other animals, air or waste pollution levels, and natural or artificial water reservoirs. While most of these factors can dictate absolute population sizes (carrying capacity), seasonal oscillations are largely driven by natural climate variations. South East Asia (SEA) is the most densely populated region of the world and has experienced rapid urbanization in the past century. Such demographic factors and tropical climate are believed be the main drivers of the success of Aedes mosquitoes in the region, the main genus for the transmission of MBVs such as DENV, CHIKV and ZIKV. Historically, surveillance of MBVs has been highly heterogeneous in the region. For instance, a few countries such as Vietnam, Thailand and Singapore often serve as global references for DENV epidemiology, reporting spatio-temporal epidemiological and genetic data spanning

Nation-wide vector surveillance did not indicate transmission of the “American lineage pandemic ZIKA virus” in India

2021

Background In wake of the global health emergency declared by the World Health Organization (WHO) during 2016, on the outbreak of ZIKA pandemic, Indian Council of Medical Research (ICMR) carried out countrywide vector surveillance for ZIKA and DENGUE viruses (ZIKV & DENV) in India, as a preparedness measure. Methods The study incorporated high-risk zones distributed to 49 Districts in 14 states/ Union Territories (UT) of India during 2016-2019. Seven ICMR Institutions undertook the study, following a uniform Standard Operating Protocol. Aedes specimens sampled on weekly intervals were processed by multiplex Reverse transcriptase PCR for ZIKV/DENV and Real time RT-PCR of ZIKV, among few samples distributed to all the Districts. Results Altogether, 79492 specimens of Aedes mosquitoes in 6492 pools were processed for both ZIKV and DENV infections. Among these, three and 63 pools respectively were found positive for ZIKV and DENV. ZIKV infections were recorded from Aedes aegypti sampled...